Healthcare price transparency in North America and Europe
The British Journal of Radiology · 2023-11 · 96 (1151)
DOI: 10.1259/bjr.20230236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The British Journal of Radiology, 2023-11. Verfasst von Harman Araich und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Case Western Reserve University, Ohio, Cleveland, United States. Hauptthemen laut MEDLINE: Delivery of Health Care, Health Care Costs. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Healthcare price transparency is an effort to inform patient decision-making, but also to decrease prices and their variation across healthcare systems for equivalent medical services. The initiative is meaningful only for medical services that are shoppable—such as imaging examinations—for which patients incur out-of-pocket costs. Therefore, several countries in which patients commonly share a portion of their healthcare costs have been implementing mandates to improve healthcare price transparency. However, the provisional implementation has many issues, especially in the United States, including provider non-compliance and limited accessibility of price transparency tools by the general public. Many of the existing tools are not user-friendly, are difficult to navigate, focus on charges and health plan negotiated rates rather than patients’ out-of-pocket costs, and disclose prices on the service level instead of per episode of care. As such, the disclosed amounts are often not reliable. Many price transparency tools also lack valid and measurable quality metrics, which can result in a selection of high-cost care as a proxy for high-value care, as well as an increase in healthcare prices when providers want to imply they offer high-quality care. Nevertheless, the impact of the initiatives on patients’ decision-making and healthcare costs remains unclear. While transparency initiatives are patient-centric, efforts should be made to increase patient engagement, provide accurate patient-specific out-of-pocket cost information, compare available treatment and provider alternatives, and couple price information with quality metrics to enable making fully informed decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, Case Western Reserve University, Ohio, Cleveland, United States.
- Department of Radiological Sciences, University of California Irvine, Orange, United States.
- Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia, United States.
- Department of Health Policy and Management, Emory University, Atlanta, Georgia, United States.
ORCID-Profile: Gelareh Sadigh
Zitieren
APA
Araich, H., Tran, J., Jung, J., Horný, M., & Sadigh, G. (2023). Healthcare price transparency in North America and Europe. The British Journal of Radiology, 96(1151). https://doi.org/10.1259/bjr.20230236
Vancouver
Araich H, Tran J, Jung J, Horný M, Sadigh G. Healthcare price transparency in North America and Europe. The British Journal of Radiology. 2023;96(1151). doi:10.1259/bjr.20230236
BibTeX
@article{Araich2023,
author = {Araich, Harman and Tran, Julia and Jung, Jinho and Horný, Michal and Sadigh, Gelareh},
title = {Healthcare price transparency in North America and Europe},
journal = {The British Journal of Radiology},
year = {2023},
volume = {96},
number = {1151},
doi = {10.1259/bjr.20230236}
}
EUVIMED